| Long-lasting treatment effect of rituximab in MuSK myasthenia J Díaz-Manera, E Martínez-Hernández, L Querol, R Klooster, ... Neurology 78 (3), 189-193, 2012 | 359 | 2012 |
| Antibodies to contactin‐1 in chronic inflammatory demyelinating polyneuropathy L Querol, G Nogales‐Gadea, R Rojas‐Garcia, E Martinez‐Hernandez, ... Annals of neurology 73 (3), 370-380, 2013 | 352 | 2013 |
| JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis L Ladislau, X Suárez-Calvet, S Toquet, O Landon-Cardinal, D Amelin, ... Brain 141 (6), 1609-1621, 2018 | 196 | 2018 |
| Altered RIG‐I/DDX58‐mediated innate immunity in dermatomyositis X Suárez‐Calvet, E Gallardo, G Nogales‐Gadea, L Querol, M Navas, ... The Journal of pathology 233 (3), 258-268, 2014 | 113 | 2014 |
| Dermatomyositis with or without anti-melanoma differentiation-associated gene 5 antibodies: common interferon signature but distinct NOS2 expression Y Allenbach, G Leroux, X Suárez-Calvet, C Preusse, E Gallardo, ... The American Journal of Pathology 186 (3), 691-700, 2016 | 99 | 2016 |
| A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss E Servián‐Morilla, H Takeuchi, TV Lee, J Clarimon, F Mavillard, ... EMBO molecular medicine 8 (11), 1289-1309, 2016 | 96 | 2016 |
| Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy N De Luna, E Gallardo, C Sonnet, B Chazaud, R Dominguez-Perles, ... Journal of Neuropathology & Experimental Neurology 69 (6), 643-653, 2010 | 48 | 2010 |
| Analysis of serum miRNA profiles of myasthenia gravis patients G Nogales-Gadea, A Ramos-Fransi, X Suarez-Calvet, M Navas, ... PloS one 9 (3), e91927, 2014 | 47 | 2014 |
| Platelet-derived growth factor BB influences muscle regeneration in Duchenne muscle dystrophy P Piñol-Jurado, E Gallardo, N de Luna, X Suárez-Calvet, ... The American Journal of Pathology 187 (8), 1814-1827, 2017 | 42 | 2017 |
| Clinical and laboratory features in anti-NF155 autoimmune nodopathy L Martín-Aguilar, C Lleixà, E Pascual-Goñi, M Caballero-Ávila, ... Neurology: Neuroimmunology & Neuroinflammation 9 (1), e1098, 2021 | 41 | 2021 |
| RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis X Suárez-Calvet, E Gallardo, I Pinal-Fernandez, N De Luna, C Lleixà, ... Arthritis research & therapy 19, 1-7, 2017 | 41 | 2017 |
| Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis N De Luna, X Suárez-Calvet, C Lleixà, J Diaz-Manera, M Olivé, I Illa, ... Scientific reports 7 (1), 8595, 2017 | 36 | 2017 |
| Nintedanib decreases muscle fibrosis and improves muscle function in a murine model of dystrophinopathy P Piñol-Jurado, X Suárez-Calvet, E Fernández-Simón, E Gallardo, ... Cell death & disease 9 (7), 776, 2018 | 33 | 2018 |
| Identification of serum microRNAs as potential biomarkers in Pompe disease A Carrasco‐Rozas, E Fernández‐Simón, MC Lleixà, I Belmonte, ... Annals of Clinical and Translational Neurology 6 (7), 1214-1224, 2019 | 22 | 2019 |
| Autoantibody screening in Guillain–Barré syndrome C Lleixà, L Martín-Aguilar, E Pascual-Goñi, T Franco, M Caballero, ... Journal of neuroinflammation 18, 1-13, 2021 | 21 | 2021 |
| Inverse association between circulating monocyte-platelet complexes and inflammation in ulcerative colitis patients C Zamora, E Canto, JC Nieto, E Garcia-Planella, J Gordillo, MA Ortiz, ... Inflammatory Bowel Diseases 24 (4), 818-828, 2018 | 17 | 2018 |
| Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis X Suárez-Calvet, J Alonso-Pérez, I Castellví, A Carrasco-Rozas, ... Neurology: Neuroimmunology & Neuroinflammation 7 (3), e694, 2020 | 13 | 2020 |
| Clinical and genetic spectrum of a large cohort of patients with δ-sarcoglycan muscular dystrophy J Alonso-Pérez, L González-Quereda, C Bruno, C Panicucci, A Alavi, ... Brain 145 (2), 596-606, 2022 | 12 | 2022 |
| RhoA/ROCK2 signalling is enhanced by PDGF‐AA in fibro‐adipogenic progenitor cells: implications for Duchenne muscular dystrophy E Fernández‐Simón, X Suárez‐Calvet, A Carrasco‐Rozas, ... Journal of Cachexia, Sarcopenia and Muscle 13 (2), 1373-1384, 2022 | 11 | 2022 |
| Study of the effect of anti-rhGAA antibodies at low and intermediate titers in late onset Pompe patients treated with ERT E Fernández-Simón, A Carrasco-Rozas, E Gallardo, L González-Quereda, ... Molecular Genetics and Metabolism 128 (1-2), 129-136, 2019 | 11 | 2019 |
